Lockheed Martin's Q2 2026 earnings release, filed as a 10-Q on July 23, 2026 for the period ending June 28, 2026, delivered a headline beat that sent the stock up 10.54% on July 24 — but the underlying print is considerably more complicated than the price action implies. The adjusted EPS of $7.94 cleared the consensus estimate of $7.23 by a meaningful margin, and revenue of $20.06 billion edged past expectations, yet the SEC-reported trailing figures — $14.38 in EPS against $59.81 billion in revenue — anchor a valuation context that the single-quarter beat does not resolve. What the print actually revealed is a company generating thin operating margins against a revenue base that is scaling, while trading at a multiple that presupposes a margin expansion trajectory the Q2 line items do not yet confirm.
Print Scorecard — Q2 2026
| Metric | Actual | Estimate | Surprise |
|---|---|---|---|
| EPS (Adjusted) | $7.94 | $7.23 | +9.82% |
| Revenue | $20.063B | ~$20.055B* | +0.04% |
| Gross Margin | 7.56% | — | — |
| Operating Margin | 7.59% | — | — |
| Net Margin | 5.56% | — | — |
*Implied estimate derived from reported surprise percentage.
Sources: LMT 10-Q filed 2026-07-23, period ending 2026-06-28; Benzinga consensus estimates.
The EPS surprise of approximately 9.82% is operationally meaningful — this is not a one-cent beat. The revenue surprise, however, is negligible at 0.04%, which means the EPS outperformance was driven primarily by something below the revenue line: cost control, favorable program mix, a tax item, or share count reduction. Without the full segment disclosure granularity, the precise driver warrants scrutiny, but the margin structure visible in the filing provides a starting point.
Narrative Test
The prevailing narrative entering Q2 was straightforward: Lockheed Martin offers modest growth at a modest price, anchored by a large funded backlog, durable F-35 demand, and participation in the Golden Dome missile-defense initiative. The characterization was that the story "checked out" against official filings and that the company had recently beaten earnings while raising its outlook.
The Q2 print partially confirms the growth dimension — revenue at $20.06 billion on a trailing twelve-month base of $59.81 billion reflects a business of genuine scale, and the record backlog commentary in management's own language ("will fuel sales growth for years to come," per Benzinga, July 24, 2026) is consistent with the funded backlog thesis. The earnings beat is real. The guidance increase is real.
What the print complicates is the "modest price" component of the narrative. A trailing P/E of 24.94x against a net margin of 5.56% and an operating margin of 7.59% describes a defense prime contractor being priced closer to a software franchise than its margin profile warrants. The 35.20% fifty-two-week return, combined with a market capitalization of $130.8 billion against trailing revenue of $59.81 billion, implies a price-to-sales ratio of approximately 2.19x — elevated by historical defense sector standards. The narrative that this is a "reasonable price" entry is the element the print most directly strains, not refutes outright.
Forensic Dissection
The margin structure disclosed in the 10-Q filed July 23, 2026 is the central forensic issue. A gross margin of 7.56% and an operating margin of 7.59% — a spread of only three basis points — implies that operating expenses beyond cost of goods are nearly negligible, or more likely, that cost of revenues is absorbing the vast majority of revenue and that the operating line includes items that are partially offsetting. The near-convergence of gross and operating margin is an unusual artifact that warrants verification against the full segment filing.
Net margin of 5.56% on $20.06 billion in Q2 revenue implies net income of approximately $1.115 billion for the quarter. Against the SEC-reported trailing EPS of $14.38, and the adjusted Q2 EPS of $7.94, there is a substantial gap between GAAP and adjusted earnings that demands examination. If the trailing twelve-month GAAP EPS is $14.38 while the single Q2 adjusted quarter produced $7.94, the implied annualized adjusted run-rate of roughly $31.76 diverges sharply from the GAAP trailing figure — a divergence that typically reflects restructuring charges, pension adjustments, or non-cash items being excluded from the adjusted figure.
The 10.54% post-print price appreciation on July 24, 2026 is disproportionate relative to a 0.04% revenue surprise. The market is repricing guidance and backlog durability, not the Q2 revenue print itself. That is a narrative-driven move, not a fundamental-driven one.
The competitive context adds another layer. Reuters reported, contemporaneously, that European customers are pressing for local defense procurement control — a structural headwind for any U.S. prime that has priced in export demand continuation. Anduril's reported $100 billion valuation fundraising round signals that capital is rotating toward non-traditional defense technology platforms, which creates a long-duration competitive overhang for legacy primes regardless of near-term backlog strength.
Four-Bullet Watchlist
- Adjusted-to-GAAP EPS reconciliation: The gap between the trailing SEC EPS of $14.38 and the Q2 adjusted $7.94 requires full disclosure of exclusions; monitor whether non-recurring items are becoming recurring in character across subsequent filings.
- Operating margin trajectory by segment: A 7.59% operating margin is structurally thin for a defense prime; watch for Aeronautics, Missiles and Fire Control, and Space segment margin disclosures in the Q3 10-Q to determine whether mix shift or program cost growth is the primary constraint.
- European export pipeline: Given Reuters reporting on Europe's drive for local procurement control, monitor any Q3 guidance revision that references international F-35 deliveries or missile-defense contract awards outside the domestic Golden Dome program.
- Valuation compression risk: With a trailing P/E of 24.94x against a net margin of 5.56% and a fifty-two-week return of 35.20% already embedded, any guidance miss or backlog conversion slowdown in Q3 would likely trigger a multiple compression event with limited cushion from the underlying earnings yield.
The Q2 print confirmed that Lockheed Martin's operational execution is credible and that its funded backlog provides genuine revenue visibility, but the margin structure and valuation premium now require a pace of earnings-per-share growth that the disclosed profitability ratios do not independently justify.